companyprofile

Actions

Dr. Sulaiman Al Habib Medical Services Group

4013
SULAIMAN ALHABIB
Add To Watchlist
In your Watchlist
Add To Watchlist
  • Main Market
  • Health Care Equipment & Svc

Stats Overview

  • Prev. Close 289.80
  • Open 290.80
  • High 294.60
  • Low 290.40
  • No. of Trades 3,313
  • Avg. Trade size* 60
  • Volume Traded 198,112
  • Value Traded (SAR) 57,927,453.20

Performance

SULAIMAN ALHABIB
2.00 ( 0.69% )
Compare
Name Price Change %
Dr. Sulaiman Al Habib Medical Services Group 290.80 0.69%
Note: Prices are delayed minimum 5 minutes
  • *Average Trade Size = Cumulative / # of Trades
  • **52 Week Price Change =   (Current Price - Price year ago) / Price year ago x 100
  • Historical prices & volume traded data are adjusted to account for all corporate actions.
  • MO: Market Order

Trade Updates

Last Trade

Price
291.80
% Change
0.69
Volume Traded
14

Best Bid

Price 291.80
Volume 983

Best Offer

Price 292.00
Volume 140

52 WEEK

High
346.80
2024/02/20
Low
223.20
2023/10/24
Change**
2.96

PERFORMANCE

Start of Year
288.2
Year ago
283.4
3 Years ago
148

Compare Selected

Select a Maximum of 5 Companies

Compare Selected

LoginPortletPopupv2

Actions

AddtoWatchlistv2

Actions

Add to watchlist

AnnouncmentandCorporateAction

Actions
Jump To :
  • Announcements & Corporate Actions
  • Dividends
  • Financials
  • Shareholding
  • Peer Comparison
  • Company Profile

Announcements

  • Dr. Sulaiman Al Habib Medical Services Group announces the board of director’s decision to distribute cash dividends for First quarter of the fiscal year 2024

    4013
    SULAIMAN ALHABIB 0.69 %
    1445/11/11     19/05/2024 07:40:14
  • Dr. Sulaiman Al Habib Medical Services Group Announces the Results of the Extraordinary General Assembly Meeting (First Meeting)

    4013
    SULAIMAN ALHABIB 0.69 %
    1445/11/07     15/05/2024 08:02:56
  • Dr. Sulaiman Al Habib Medical Services Group announces its Interim Financial results for the Period Ending on 2024-03-31 ( Three Months )

    4013
    SULAIMAN ALHABIB 0.69 %
    1445/10/19     28/04/2024 08:02:33
  • Dr. Sulaiman Al Habib Medical Services Group Board invites its Shareholders to attend the Extraordinary General Assembly Meeting (First Meeting) via modern technology means

    4013
    SULAIMAN ALHABIB 0.69 %
    1445/10/05     14/04/2024 15:47:29
  • Dr. Sulaiman Al Habib Medical Services Group Announces an update on the Group’s Announcement on the latest developments in the Works of Al-Fayhaa Hospital Project in Jeddah Governorate

    4013
    SULAIMAN ALHABIB 0.69 %
    1445/09/14     24/03/2024 09:03:55
View All

Corporate Actions

Upcoming Events

    Past Events

      Jump To :
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Dividends

      Announced Date Eligibility Date Distribution Date Distribution Way Dividend Amount
      18/02/2024 21/02/2024 04/03/2024 Account Transfer 1.15
      29/10/2023 02/11/2023 20/11/2023 Account Transfer 1.17
      06/08/2023 10/08/2023 28/08/2023 Account Transfer 1.00
      07/05/2023 11/05/2023 29/05/2023 Account Transfer 1.00
      19/02/2023 23/02/2023 13/03/2023 Account Transfer 0.93

      CompanyProfilev2Financials

      Actions
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Financials

      • FINANCIAL INFORMATION
      • FINANCIAL STATEMENTS AND REPORTS
      • Annually
      • Quarterly
      Balance Sheet 2023-12-31
      Total Assets
      15,798,042
      - - -
      Total Liabilities
      9,031,800
      - - -
      Total Shareholders Equity (After Deducting the Minority Equity)
      6,485,485
      - - -
      Total Liabilities and Shareholders Equity
      15,798,042
      - - -
      Statement of Income 2023-12-31
      Total Revenue (Sales/Operating)
      9,508,439
      - - -
      Net Profit (Loss) before Zakat and Tax
      2,114,530
      - - -
      Zakat and Income Tax
      -68,516
      - - -
      Net Profit (Loss) after Zakat and Tax
      2,046,014
      - - -
      Total Comprehensive Income
      2,041,792
      - - -
      Profit (Loss) per Share
      5.85
      - - -
      Cash Flow 2023-12-31
      Net Cash From Operating Activities
      3,244,152
      - - -
      Net Cash From Investing Activities
      -3,486,628
      - - -
      Net Cash From Financing Activities
      115,867
      - - -
      Cash and Cash Equivalents, Beginning of the Period
      2,746,989
      - - -
      Cash and Cash Equivalents, End of the Period
      2,620,380
      - - -
      All Figures in Thousands
      All Currency In SAR
      Last Update Date 2024-02-20

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Balance Sheet 2024-03-31 2023-09-30
      Total Assets
      16,848,732
      15,128,429
      Total Liabilities
      9,912,398
      8,475,079
      Total Shareholders Equity (After Deducting the Minority Equity)
      6,634,882
      6,392,830
      Total Liabilities and Shareholders Equity
      16,848,732
      15,128,429
      Statement of Income 2024-03-31 2023-09-30
      Total Revenue (Sales/Operating)
      2,521,409
      2,442,807
      Net Profit (Loss) before Zakat and Tax
      566,459
      571,622
      Zakat and Income Tax
      -15,510
      26,855
      Net Profit (Loss) after Zakat and Tax
      550,949
      544,767
      Total Comprehensive Income
      551,897
      545,758
      Profit (Loss) per Share
      1.57
      1.56
      Cash Flow 2024-03-31 2023-09-30
      Net Cash From Operating Activities
      795,752
      2,065,681
      Net Cash From Investing Activities
      -1,062,373
      -2,698,046
      Net Cash From Financing Activities
      175,511
      336,116
      Cash and Cash Equivalents, Beginning of the Period
      2,620,380
      2,746,989
      Cash and Cash Equivalents, End of the Period
      2,529,270
      2,450,740
      All Figures in Thousands Thousands
      All Currency In SAR SAR
      Last Update Date 2024-04-28 2023-10-30

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of this disclosure, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of this disclosure, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate. The above information does not replace detailed financial statements, as detailed financial statements are the reliable source that must be consulted to obtain accurate financial information.

      Display Previous Periods
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Shareholding Information

      • Board Of Directors
      • Foreign Ownership
      • Substantial Shareholders
      Time Period
      -
      Search
      Trading Date Shareholders Designation Shares Held Trading Day Shares Held Prev Trading Day Change
      2024-05-21 سليمان عبدالعزيز سليمان الحبيب Chairman 40.0300000% 40.0300000% 0
      2024-05-21 هشام سليمان عبدالعزيز الحبيب Board of Directors 2.0000000% 2.0000000% 0
      2024-05-21 عبيد عبدالله عبيد الرشيد Board of Directors 0.0063429% 0.0063429% 0
      2024-05-21 مازن عبدالرزاق سليمان الرميح Board of Directors 0.0228571% 0.0226794% 0.0001777
      2024-05-21 عبدالرحمن سليمان حمود الطريقي Board of Directors 0.0000043% 0.0000043% 0
      • The listed company (Publisher) shall be responsible for the accuracy of the published information pertaining to the ownership of the Board of Directors, Chief Executive Officer or highest executive position, and the Chief Financial Officer. The listed company shall also be responsible for updating these information thereof. Therefore, the Saudi Stock Exchange (Tadawul) shall not be liable for the information contained therein, nor for any consequences that may result from the said information.
      for
      subs
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Peer Comparison

      • Table
      • Graphical
      Add Company

      Compare Selected

      Select a Maximum of 5 Companies

      Company Apply
      Dr. Sulaiman Al Habib Medical Services Group
      Price 291.80
      Market Cap (SAR MN) 106,120
      P/E Ratio 51.87
      Index Name Index Level 1D Return
      Dr. Sulaiman Al Habib Medical Services Group %
      Jump To:
      • Announcements & Corporate Actions
      • Dividends
      • Financials
      • Shareholding
      • Peer Comparison
      • Company Profile

      Company Profile

      Company overview

      The Group''s main activities are to provide private healthcare services and related support services for its operations in the Kingdom and the region by establishing, managing and hospitals, general and specialized medical complexes, one-day surgery centers, and pharmaceutical facilities, and other support areas which include home healthcare services, specialized medical laboratories, information technology systems services, and facility maintenance services.

      Company History

      The Company was established as a sole proprietorship under the name of (Dr. Sulaiman Abdulaziz Al Habib Medical Services Clinics Complex) under Commercial Registration No. 1010118330 dated 11/06/1414H (25/11/1993G), with a share capital amounting to (SAR 100,000). On 23/05/1428H (10/06/2007G), the sole proprietorship was converted to a limited liability company under the name of (Dr. Sulaiman Al Habib Medical Services Clinics Complex Company), with a capital of (SAR 500,000) consisting of five hundred (500) shares each valued at one thousand Saudi Riyals (SAR 1,000). On 11/07/1431H (23/06/2010G), the Company changed its name to (Dr. Sulaiman Al Habib Medical Services Clinics Complex Holding Company). On 27/01/1435H (30/11/2013G), the Company''s capital was increased to SAR 2,000,000 divided into 200,000 shares, with a nominal value of SAR 10 per share. On 26/02/1435H, (29/12/2013G), the Company was converted from a limited liability company into a closed joint stock company under Minister of Commerce and Industry Resolution No. 38/Q dated 26/02/1435H (29/12/2013G). On 19/08/1435H (corresponding to 17/06/2014G), the Extraordinary General Assembly approved to change its name to (Dr. Sulaiman Al Habib Medical Services Group Holding Company). On 01/04/1436H (21/01/2015G), the Extraordinary General Assembly increased the Company''s capital to (SAR 2,800,000,000) divided into 280,000,000 ordinary shares, with a nominal value of SAR 10 per share. On 26/10/1436H (11/08/2015G), the Extraordinary General Assembly increased the Company''s capital to three billion, five hundred million Saudi Riyals (SAR 3,500,000,000) divided into three hundred fifty million (350,000,000) ordinary shares, with a nominal value of ten Saudi Riyals (SAR 10) per share. On 10/01/1438H (11/10/2016G), the Extraordinary General Assembly decided to change the Company''s name again to become (Dr. Sulaiman Al Habib Medical Services Group Company).

      Company Bylaws

      Click here

      Equity Profile

      • Authorized Capital (SAR) 3,500,000,000
      • Issued Shares 350,000,000
      • Paid Capital (SAR) 3,500,000,000
      • Par Value/Share 10
      • Paid Up Value/Share 10

      Last Update :2020-03-16

      Investment limits

      There are no investment limits on the company shares as per the amended Rules for Qualified Foreign Financial Institutions investment in Listed Securities and instructions for the Foreign Strategic Investors Ownership in Listed Companies based on company bylaw and the issued instructions by the related regulators and supervisory authorities

       

      • Company Details
      • BOARD OF DIRECTORS AND SENIOR EXECUTIVES INFORMATION
      • Date Established

        1993/11/25

      • Financial Year End

        31/12

      • Listing Date

        2020/03/17

      • External Auditors

        [Ernst & Young & Associates]

      • ISIN CODE

        SA1510P1UMH1

      • Number of Employees

        10475

      • Chairman

        Dr. Sulaiman Abdulaziz Sulaiman AlHabib
        Non - Executive

        Dr. Sulaiman Abdulaziz Sulaiman AlHabib
        • BD Session Start
          2021-12-10
          Designation
          Chairman
        • BD Session End
          2024-12-09
          Classification
          Non - Executive
        • Qualification
          Fellowship in Pediatrics from the Royal College of Physicians in 1984G Bachelor degree in Medicine and Surgery from Faculty of Medicine, King Saud University, Riyad
      • Board of Directors

        Mazen Abdulrazak Sulaiman AlRumaih Deputy Chairman - Non Executive

        Mazen Abdulrazak Sulaiman AlRumaih
        • BD Session Start
          2021-12-10
          Designation
          Board of Directors
        • BD Session End
          2024-12-09
          Classification
          Deputy Chairman - Non Executive
        • Qualification
          Bachelor degree in Accounting and Financial Management from the University of Buckingham, UK, in 1994G

        Saleh Muhammad Abdulaziz AlHabib Non - Executive

        Saleh Muhammad Abdulaziz AlHabib
        • BD Session Start
          2021-12-10
          Designation
          Board of Directors
        • BD Session End
          2024-12-09
          Classification
          Non - Executive
        • Qualification
          Bachelor degree in Architecture, King Saud University, Riyadh, 2000G

        Hisham Sulaiman Abdulaziz AlHabib Executive

        Hisham Sulaiman Abdulaziz AlHabib
        • BD Session Start
          2021-12-10
          Designation
          Board of Directors
        • BD Session End
          2024-12-09
          Classification
          Executive
        • Qualification
          Bachelor degree in Financial Management from American University of Sharjah, United Arab Emirates, 2009G

        Dr. Abdulrahman Sulaiman Hmoud Al Turaigi Independent

        Dr. Abdulrahman Sulaiman Hmoud Al Turaigi
        • BD Session Start
          2021-12-10
          Designation
          Board of Directors
        • BD Session End
          2024-12-09
          Classification
          Independent
        • Qualification
          Ph.D.in Engineering Management from University of Missouri, USA, 1997G Bachelor degree in Engineering Management from University of Missouri, USA, 1994G Master degree in Industrial Systems Engineering from University of Michigan, USA, 1990G Bachelor degree in Industrial Systems Engineering from King Saud University, KSA, 2000G

        Ubaid Abdullah Ubaid Al-Rashid Independent

        Ubaid Abdullah Ubaid Al-Rashid
        • BD Session Start
          2021-12-10
          Designation
          Board of Directors
        • BD Session End
          2024-12-09
          Classification
          Independent
        • Qualification
          Bachelor degree of Business Administration, San Jose State University, California, USA, 1983G

        Rasheed Abdulrahman Nasser AL Rasheed Independent

        Rasheed Abdulrahman Nasser AL Rasheed
        • BD Session Start
          2021-12-10
          Designation
          Board of Directors
        • BD Session End
          2024-12-09
          Classification
          Independent
        • Qualification
          Higher Diploma in Management Information Technology Systems from King Saud University, KSA, 1988G

        Faisal Abdullah Ali Al-Nassar Executive

        Faisal Abdullah Ali Al-Nassar
        • BD Session Start
          2021-12-10
          Designation
          Board of Directors
        • BD Session End
          2024-12-09
          Classification
          Executive
        • Qualification
          Bachelor degree in Accounting and Information Systems, College of Industrial Management, King Fahd University of Petroleum and Minerals in Dhahran, 2001G
      • Senior Executives

        Faisal Abdullah Ali Al-Nassar CEO

        Faisal Abdullah Ali Al-Nassar
        • BD Session Start
          2023-10-08
          Designation
          Senior Executives
        • BD Session End
          -
          Classification
          CEO

        Faisal Abdullah Ali Al-Nassar CFO

      Faisal Abdullah Ali Al-Nassar
      • BD Session Start
        2011-10-02
        Designation
        Senior Executives
      • BD Session End
        -
        Classification
        CFO

      Investor Relations

      Contact Name:

      Investor Relations

      Company Address:

      P.O. Box 301578 Riyadh 11372

      Contact Details:

      Telephone: 966115259999+
      Fax : 966114620096+
      Email : investor.relations@drsulaimanalhabib.com

      Company Website:

      www.hmg.com


      Name Of Subsidiary Percentage Of Property Main Business Location Of Operation Country Of Operation
      Sehat Al Olaya Medical Complex Company 100.00% Hospital Saudi Arabia Saudi Arabia
      Asharq Alawsat Pharmacies Company 100.00% Pharmacy Saudi Arabia Saudi Arabia
      Dr. Sulaiman Al Habib Hospital FZ/LLC 100.00% Hospital UAE UAE
      Buraidah Al Takhassusi Hospital for Healthcare Company 100.00% Hospital Saudi Arabia Saudi Arabia
      Al Rayan Hospital for Healthcare Company 100.00% Hospital Saudi Arabia Saudi Arabia
      Home Healthcare Company 100.00% Home Healthcare services Saudi Arabia Saudi Arabia
      Al Gharb Al Takhassusi Hospital for Healthcare Company 100.00% Hospital Saudi Arabia Saudi Arabia
      Al Mokhtabarat Diagnostic Medical Company 100.00% Laboratory Services Saudi Arabia Saudi Arabia
      Sehat Al Suwaidi Medical Company 100.00% Hospital Saudi Arabia Saudi Arabia
      Hulool Al Sahaba for IT & Communication Company 100.00% IT Support Services Saudi Arabia Saudi Arabia
      Intensive Care Company for Healthcare 100.00% Medical Services Saudi Arabia Saudi Arabia
      Sehat Al Sharq Medical Limited Company 50.00% Hospital Saudi Arabia Saudi Arabia
      Al Wosta Medical Limited Company 50.00% Hospital Saudi Arabia Saudi Arabia
      Gharb Jeddah Hospital Company 50.00% Hospital Saudi Arabia Saudi Arabia
      Shamal Al Riyadh for Healthcare Company 100.00% Hospital Saudi Arabia Saudi Arabia
      Al Muhammadiyah Hospital for Healthcare Company 100.00% Hospital Saudi Arabia Saudi Arabia
      Taswyat Management Company 100.00% Revenue cycle management Saudi Arabia Saudi Arabia
      Al Marakez Al Awwalyah for Health Care Company 100.00% Medical Primary Healthcare centers Saudi Arabia Saudi Arabia
      Rawabet Medical Company 100.00% Telemedicine services Saudi Arabia Saudi Arabia
      Flow Medical Company 100.00% Medical equipments maintenance Saudi Arabia Saudi Arabia
      Sehat Al Kharj for Healthcare Company 100.00% Hospital Saudi Arabia Saudi Arabia
      Add To Watchlist
      In your Watchlist
      Add To Watchlist

      The Capital Market Authority and Saudi Exchange take no responsibility for the contents of these disclosures, make no representations as to its accuracy or completeness, and expressly disclaim any liability whatsoever for any loss arising from, or incurred in reliance upon, any part of these disclosures, and the issuer accepts full responsibility for the accuracy of the information contained in it and confirms, having made all reasonable enquiries, that to the best of their knowledge and belief, there are no other facts or information the omission of which would make the disclosure misleading, incomplete or inaccurate.